Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 2828

1.

New world order(s): healthcare metrics, international borders, and gravitational waves.

Tewari KS.

Gynecol Oncol. 2014 May;133(2):139-41. doi: 10.1016/j.ygyno.2014.04.001. No abstract available.

PMID:
24773670
[PubMed - indexed for MEDLINE]
2.

[Experimental technology of chemoperfusion treatment for abdominal carcinomatosis in ovarian cancer].

Beliaeva OA, Bespalov VG, Senchik KIu, Kireeva GS, Stukov AN, Aristova VA, Ivantsov AO, Vyshinskaia EA, Maĭdin MA, Semënov AL, Aleksandrov VA, Beliaev AM.

Vopr Onkol. 2014;60(1):71-9. Russian.

PMID:
24772620
[PubMed - indexed for MEDLINE]
3.

Is it possible to define an optimal time for chemotherapy after surgery for ovarian cancer?

Lydiksen L, Jensen-Fangel S, Blaakaer J.

Gynecol Oncol. 2014 Jun;133(3):454-9. doi: 10.1016/j.ygyno.2014.04.004. Epub 2014 Apr 12.

PMID:
24726613
[PubMed - indexed for MEDLINE]
4.

Efficacy and safety of AEZS-108 (INN: zoptarelin doxorubicin acetate) an LHRH agonist linked to doxorubicin in women with platinum refractory or resistant ovarian cancer expressing LHRH receptors: a multicenter phase II trial of the ago-study group (AGO GYN 5).

Emons G, Gorchev G, Sehouli J, Wimberger P, Stähle A, Hanker L, Hilpert F, Sindermann H, Gründker C, Harter P.

Gynecol Oncol. 2014 Jun;133(3):427-32. doi: 10.1016/j.ygyno.2014.03.576. Epub 2014 Apr 5.

PMID:
24713545
[PubMed - indexed for MEDLINE]
5.

Randomised phase II study of docetaxel plus vandetanib versus docetaxel followed by vandetanib in patients with persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: SWOG S0904.

Coleman RL, Moon J, Sood AK, Hu W, Delmore JE, Bonebrake AJ, Anderson GL, Chambers SK, Markman M.

Eur J Cancer. 2014 Jun;50(9):1638-48. doi: 10.1016/j.ejca.2014.03.005. Epub 2014 Apr 4.

PMID:
24709487
[PubMed - indexed for MEDLINE]
6.

Impact of combination chemotherapy with itraconazole on survival for patients with recurrent or persistent ovarian clear cell carcinoma.

Tsubamoto H, Sonoda T, Yamasaki M, Inoue K.

Anticancer Res. 2014 Apr;34(4):2007-14.

PMID:
24692739
[PubMed - indexed for MEDLINE]
7.

Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS).

Au-Yeung G, Webb PM, DeFazio A, Fereday S, Bressel M, Mileshkin L.

Gynecol Oncol. 2014 Apr;133(1):16-22. doi: 10.1016/j.ygyno.2014.01.030.

PMID:
24680586
[PubMed - indexed for MEDLINE]
8.

Analysis of operative morbidity in a single center initial experience with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Graziosi L, Mingrone E, Marino E, Cavazzoni E, Donini A.

Tumori. 2014 Jan-Feb;100(1):15-20. doi: 10.1700/1430.15809.

PMID:
24675485
[PubMed - indexed for MEDLINE]
9.

Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).

Robella M, Vaira M, Marsanic P, Mellano A, Borsano A, Cinquegrana A, Sottile A, De Simone M.

Minerva Chir. 2014 Feb;69(1):27-35.

PMID:
24675244
[PubMed - indexed for MEDLINE]
10.

Peritonectomy and hyperthermic chemotherapy in patients with advanced or recurrent ephitelial ovarian cancer: a single center cohort study.

Massari R, Barone M, Basilico R, Carella C, Colasante A, De Tursi M, Filippone A, Guetti L, Mani A.

Minerva Chir. 2014 Feb;69(1):17-26.

PMID:
24675243
[PubMed - indexed for MEDLINE]
11.

Chemotherapy-induced neutropenia as a biomarker of survival in advanced ovarian carcinoma: an exploratory study of the gynecologic oncology group.

Tewari KS, Java JJ, Gatcliffe TA, Bookman MA, Monk BJ.

Gynecol Oncol. 2014 Jun;133(3):439-45. doi: 10.1016/j.ygyno.2014.03.013. Epub 2014 Mar 20.

PMID:
24657300
[PubMed - indexed for MEDLINE]
12.

PI3K/mTOR dual inhibitor NVP-BEZ235 decreases Mcl-1 expression and sensitizes ovarian carcinoma cells to Bcl-xL-targeting strategies, provided that Bim expression is induced.

Jebahi A, Villedieu M, Pétigny-Lechartier C, Brotin E, Louis MH, Abeilard E, Giffard F, Guercio M, Briand M, Gauduchon P, Lheureux S, Poulain L.

Cancer Lett. 2014 Jun 28;348(1-2):38-49. doi: 10.1016/j.canlet.2014.03.001. Epub 2014 Mar 18.

PMID:
24650799
[PubMed - indexed for MEDLINE]
Free Article
13.

[Small cell carcinoma of the ovary].

Bahri M, Lahmar R, Ben Salah H, Kallel N, Ben Amar M, Daoud J.

Cancer Radiother. 2014 Jun;18(3):198-200. doi: 10.1016/j.canrad.2014.01.002. Epub 2014 Mar 14. French.

PMID:
24637019
[PubMed - indexed for MEDLINE]
14.

Differential outcome of MEK1/2 inhibitor-platinum combinations in platinum-sensitive and -resistant ovarian carcinoma cells.

Cossa G, Lanzi C, Cassinelli G, Carenini N, Arrighetti N, Gatti L, Corna E, Zunino F, Zaffaroni N, Perego P.

Cancer Lett. 2014 Jun 1;347(2):212-24. doi: 10.1016/j.canlet.2014.02.016. Epub 2014 Feb 24.

PMID:
24576622
[PubMed - indexed for MEDLINE]
15.

Reasons for failure to deliver National Comprehensive Cancer Network (NCCN)-adherent care in the treatment of epithelial ovarian cancer at an NCCN cancer center.

Erickson BK, Martin JY, Shah MM, Straughn JM Jr, Leath CA 3rd.

Gynecol Oncol. 2014 May;133(2):142-6. doi: 10.1016/j.ygyno.2014.02.006. Epub 2014 Feb 8.

PMID:
24517876
[PubMed - indexed for MEDLINE]
16.

A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube.

Herzog TJ, Monk BJ, Rose PG, Braly P, Hines JF, Bell MC, Wenham RM, Secord AA, Roman LD, Einstein MH, Drake RD, Childs BH.

Gynecol Oncol. 2014 Mar;132(3):517-25. doi: 10.1016/j.ygyno.2014.01.035. Epub 2014 Jan 27.

PMID:
24476788
[PubMed - indexed for MEDLINE]
17.

The prognostic significance of preoperative leukocytosis in epithelial ovarian carcinoma: a retrospective cohort study.

So KA, Hong JH, Jin HM, Kim JW, Song JY, Lee JK, Lee NW.

Gynecol Oncol. 2014 Mar;132(3):551-5. doi: 10.1016/j.ygyno.2014.01.010. Epub 2014 Jan 14.

PMID:
24440470
[PubMed - indexed for MEDLINE]
18.

ERCC1 expression as a predictor of resistance to platinum-based chemotherapy in primary ovarian cancer.

Muallem MZ, Braicu I, Nassir M, Richter R, Sehouli J, Arsenic R.

Anticancer Res. 2014 Jan;34(1):393-9.

PMID:
24403493
[PubMed - indexed for MEDLINE]
19.

Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group.

Billmire DF, Cullen JW, Rescorla FJ, Davis M, Schlatter MG, Olson TA, Malogolowkin MH, Pashankar F, Villaluna D, Krailo M, Egler RA, Rodriguez-Galindo C, Frazier AL.

J Clin Oncol. 2014 Feb 10;32(5):465-70. doi: 10.1200/JCO.2013.51.1006. Epub 2014 Jan 6.

PMID:
24395845
[PubMed - indexed for MEDLINE]
20.

[A case of delayed subcutaneous metastases of gastric carcinoma effectively treated with S-1 plus cisplatin chemotherapy].

Matsuoka T, Hosaka S, Inada K, Kawamoto S.

Gan To Kagaku Ryoho. 2013 Nov;40(12):2262-4. Japanese.

PMID:
24394079
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk